Marc Beer is a prominent philanthropist for the support and development he has imposed in various health-related sectors. He is always on the front line to ensure that all patients are treated with respect and dignity. For over 25 years Marc Beer has earned extensive experience in biotechnology, diagnostic and pharmaceutical industries. He has worked in various companies serving at the top positions. Some of the companies include Anderson Pharmaceuticals where he served as the CEO. Marc Beer has also worked at ViaCell company where he played a significant role in the establishment of the company. ViaCell is a biotechnology company that specializes in collecting multiple umbilical cords and their stem cells they also ensure they are well preserved. Having Studied a B.S at Miami University based in Ohio Marc Beer served at Genzyme company that has devoted all their resources to establish treatments for all diseases that are difficult to be treated and diagnosed. He earned extensive experience working in these companies; he was able to launch Renovia company with other partners.
Marc Beer is the current CEO of Renovia company as well as the Chairman for the board of directors in the same company. Besides working at Renovia, he is the chairman at both Minerva Neuroscience and Good Start Genetics. Marc Beer has set a legacy in all these companies as he is always devoted to accomplishing all the set goals. In Renovia Marc Beer contributed to the raising of $50.3 million to fund the three rounds. On 21st August 2018, Marc Beer also raised money for the series B round. They raised about $32.3 Million with top investors like Western Technology investments, perceptive advisors and Ascension ventures. Marc Beer has also resulted in the adoption of modern technologies including SSL, iPhone, Viewport Meta among others to ensure that the company runs as planned. Marc Beer works closely with Ramon Iglesias, William Dull, Jose Bohorquez, and Jessica McKinney to ensure the smooth running of the company projects.
Recently, Marc Beer raised about $42 million to fund the establishment of a women health center based in Boston. This medical center is aimed at coming up with therapeutic, diagnostic products to aid treatment of pelvic disorders that millions of women are suffering from across the globe. Pelvic disorders include urinary inconsistency which keeps many women in discomfort. The money raised by Marc Beer`s company led to the establishment of Leva device which has been approved by FDA to be fit for diagnosing pelvic disorders.
This fund also will lead to research and combining advanced technologies to ensure that they come up with more effective treatments. Renovia has aligned with the Longwood Fund thus leading to the establishment of Missouri Ascension ventures that is devoted to transforming women lives. Learn more: https://www.bizjournals.com/boston/news/2018/08/21/ex-aegerion-chief-beer-raises-42m-for-womens.html